OrthoPediatrics (KIDS) Competitors

OrthoPediatrics (NASDAQ:KIDS) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Do institutionals & insiders hold more shares of KIDS or ATRI?

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 66.2% of Atrion shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by company insiders. Comparatively, 22.8% of Atrion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has better valuation & earnings, KIDS or ATRI?

Atrion has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$148.73M	5.22	-$20.97M	-$0.96	-33.96
Atrion	$169.33M	4.76	$19.41M	$10.64	43.01

Which has more risk & volatility, KIDS or ATRI?

OrthoPediatrics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Atrion has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

Is KIDS or ATRI more profitable?

Atrion has a net margin of 10.60% compared to OrthoPediatrics' net margin of -13.58%. Atrion's return on equity of 7.75% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-13.58%	-5.12%	-4.41%
Atrion	10.60%	7.75%	7.12%

Do analysts rate KIDS or ATRI?

OrthoPediatrics currently has a consensus price target of $44.75, suggesting a potential upside of 37.27%. Given OrthoPediatrics' higher possible upside, equities research analysts clearly believe OrthoPediatrics is more favorable than Atrion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Atrion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community prefer KIDS or ATRI?

OrthoPediatrics received 177 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.42% of users gave OrthoPediatrics an outperform vote while only 53.31% of users gave Atrion an outperform vote.

Company	Underperform	Outperform
OrthoPediatrics	Outperform Votes 306 64.42%	Underperform Votes 169 35.58%
Atrion	Outperform Votes 129 53.31%	Underperform Votes 113 46.69%

Does the media refer more to KIDS or ATRI?

In the previous week, Atrion had 3 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for Atrion and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.94 beat Atrion's score of 0.76 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Atrion	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OrthoPediatrics beats Atrion on 9 of the 17 factors compared between the two stocks.